SORTIS cpr pell 40 mg 30 pce

7680540850605 CH-54085 C10AA05 07.12.0.

Reimbursement limitations:

SORTIS

Chez les adultes de 18 à 75 ans, le traitement par statines est remboursé en …

SORTIS cpr pell 40 mg 30 pce
SORTIS cpr pell 40 mg 30 pce
SORTIS cpr pell 40 mg 30 pce
1 / 3
google

Details

Product number
5408503
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
atorvastatinum 40 mg ut atorvastatinum calcicum trihydricum 43.40 mg, calcii carbonas, cellulosum microcristallinum, lactosum monohydricum 131.22 mg, carmellosum natricum conexum corresp. natrium 3.24 mg, polysorbatum 80, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, E 171, talcum, simeticonum, polysorbatum 65, methylcellulosum, macrogoli 8 stearas typus I, glyceroli monostearas 40-55, xanthani gummi, acidum benzoicum 0.00024 mg, acidum sorbicum, acidum sulfuricum, cera candelilla, pro compresso obducto.

Articles (1)

Sortis 40, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/06/2025
Patient information leaflet
Français
06/06/2025
Patient information leaflet
Italien
06/06/2025
Professional SmPC
Allemand
06/06/2025
Professional SmPC
Français
06/06/2025
Professional SmPC
Italien
06/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
43.4 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
131.22 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
3.24 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.00024 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 37.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2002

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
54085
Drug name
Sortis, Filmtabletten
Galenic form
FILM
ATC Code
C10AA05
Authorization status
Z
Dispensation category
B
First authorization
11/06/1997
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
SORTIS cpr pell 40 mg 30 pce
Description (DE)
SORTIS Filmtabl 40 mg 30 Stk
Market launch
11/06/1997
Narcotic (BTM)
No

Available generics

Atorvastatin axapharm, Filmtabletten
CHF 30.60
View
Atorvastatin axapharm, Filmtabletten
CHF 63.00
View
Atorvastatin axapharm, Filmtabletten
CHF 30.55
View
Atorvastatin axapharm, Filmtabletten
CHF 62.90
View
Atorvastatin axapharm, Filmtabletten
CHF 30.55
View
Atorvastatin axapharm, Filmtabletten
CHF 62.90
View
Atorvastatin axapharm, Filmtabletten
CHF 30.60
View
Atorvastatin axapharm, Filmtabletten
CHF 63.05
View
Atorvastatin-Mepha, Filmtabletten
CHF 30.55
View
Atorvastatin-Mepha, Filmtabletten
CHF 58.50
View

Other packaging sizes

SORTIS cpr pell 10 mg 30 pce
30 TABL
View
SORTIS cpr pell 10 mg 100 pce
100 TABL
View
SORTIS cpr pell 20 mg 30 pce
30 TABL
View
SORTIS cpr pell 20 mg 100 pce
100 TABL
View
SORTIS cpr pell 40 mg 100 pce
100 TABL
View
SORTIS cpr pell 80 mg 30 pce
30 TABL
View
SORTIS cpr pell 80 mg 100 pce
100 TABL
View